PRKN and Hepatic fibrosis: In this study, we found that PINK1/parkin-mediated mitophagy was downregulated during the activation of HSCs and development of hepatic fibrosis, while MitoQ enhanced mitophagy and reduced ROS levels in the HSCs and reduced liver fibrosis.